IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

PERROTTA, Fabio Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.813
EU - Europa 4.736
AS - Asia 1.672
SA - Sud America 435
AF - Africa 342
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.698
RU - Federazione Russa 2.230
IE - Irlanda 776
SG - Singapore 733
CN - Cina 371
BR - Brasile 332
IT - Italia 298
CI - Costa d'Avorio 270
FR - Francia 222
DE - Germania 211
AT - Austria 194
FI - Finlandia 182
UA - Ucraina 167
GB - Regno Unito 144
VN - Vietnam 115
HK - Hong Kong 95
SE - Svezia 89
IN - India 80
PL - Polonia 79
CA - Canada 70
BD - Bangladesh 47
AR - Argentina 32
JP - Giappone 31
BE - Belgio 30
NL - Olanda 30
TR - Turchia 30
ZA - Sudafrica 28
IQ - Iraq 26
ID - Indonesia 22
ES - Italia 21
LT - Lituania 20
CO - Colombia 19
MX - Messico 19
VE - Venezuela 16
CL - Cile 12
EC - Ecuador 12
AU - Australia 11
MY - Malesia 11
PK - Pakistan 11
SA - Arabia Saudita 11
PH - Filippine 9
EU - Europa 8
IR - Iran 8
KR - Corea 8
MA - Marocco 8
UZ - Uzbekistan 8
EG - Egitto 7
JM - Giamaica 7
JO - Giordania 7
AZ - Azerbaigian 6
DZ - Algeria 6
IL - Israele 6
KE - Kenya 6
NP - Nepal 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
TN - Tunisia 5
CH - Svizzera 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
PT - Portogallo 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LK - Sri Lanka 3
NI - Nicaragua 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SV - El Salvador 3
AL - Albania 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BB - Barbados 1
BW - Botswana 1
CR - Costa Rica 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MZ - Mozambico 1
Totale 12.011
Salva come PNG Salva come JPEG
Città #
Dallas 932
Dublin 775
Moscow 749
San Jose 579
Chandler 439
Singapore 390
Jacksonville 378
Abidjan 270
Ashburn 242
Vienna 191
Helsinki 157
The Dalles 152
Beijing 124
Ann Arbor 117
Wilmington 106
Hong Kong 93
Lauterbourg 90
Los Angeles 80
San Mateo 78
Warsaw 75
New York 68
Frankfurt am Main 65
Rome 62
Princeton 61
Houston 60
Woodbridge 50
Columbus 47
Boardman 44
Ho Chi Minh City 43
Dearborn 42
Santa Clara 39
Council Bluffs 38
São Paulo 38
Orem 36
London 31
Brussels 30
Tokyo 29
Toronto 27
Chennai 23
Milan 21
Brooklyn 20
Manchester 20
Molise 20
Redwood City 20
Amsterdam 18
San Francisco 18
Hanoi 17
Montreal 17
Denver 16
Chicago 15
Johannesburg 15
Jinan 14
Ottawa 14
Atlanta 13
Naples 13
Hillsboro 12
Baghdad 11
Mountain View 11
Rio de Janeiro 11
Ankara 10
Dhaka 10
Falkenstein 10
Seattle 10
Stockholm 10
Guangzhou 9
Mexico City 9
Nanjing 9
Augusta 8
Istanbul 8
Phoenix 8
Poplar 8
Rochester 8
Borås 7
Boston 7
Esslingen am Neckar 7
Leawood 7
New Delhi 7
Shanghai 7
Shenyang 7
Tashkent 7
Zhengzhou 7
Amman 6
Ardabil 6
Caracas 6
Fortaleza 6
Haikou 6
Jakarta 6
Mumbai 6
Nairobi 6
Newark 6
Ningbo 6
Paris 6
Porto Alegre 6
Rockville 6
Seoul 6
Uberlândia 6
Baku 5
Belo Horizonte 5
Brasília 5
Changsha 5
Totale 7.456
Salva come PNG Salva come JPEG
Nome #
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica 306
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 248
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 218
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 215
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 210
An overview of low disease activity and remission in psoriatic arthritis. 207
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 190
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 186
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 183
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 182
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 181
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 181
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 176
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 176
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 168
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 168
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 167
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 162
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 156
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 154
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 151
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 149
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 147
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 145
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 144
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 144
The role of IL-17 in the treatment of psoriatic arthritis 139
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 138
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 138
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 138
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 137
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 137
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 136
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 136
Assessment of Carpal Tunnel Syndrome in Patients With Wrist Involvement During the Course of Inflammatory Arthritis. A Cross-Sectional Study 135
Dr. Lubrano, et al reply 133
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 132
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis 132
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 130
Unmet Needs in Axial Spondyloarthritis 130
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 130
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 129
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 128
Role of comorbidities in spondyloarthritis including psoriatic arthritis 128
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 127
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 126
Secukinumab for ankylosing spondylitis and psoriatic arthritis 126
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 119
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 118
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 117
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 113
Psoriatic arthritis: is it time to treat-to-target or target to treat? 111
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 110
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 109
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 109
New approved drugs for psoriatic arthritis. 107
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 106
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 106
Impact of physical activity on disability risk in elderly patients hospitalized for mild acute diverticulitis and diverticular bleeding undergone conservative management 103
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 101
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review 101
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 101
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 101
To move or not to move: The paradoxical effect of physical exercise in axial spondyloarthritis 101
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 100
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 98
Residual disease activity and associated factors in Psoriatic Arthritis 98
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 97
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 93
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 93
Psoriatic Arthritis in Males and Females: Differences and Similarities 92
Rheumatology Care in the Face of COVID-19 90
Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms 88
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 85
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis 83
Valutazione ecografica del tendine di Achille e dell'entesi rotulea nei giocatori di calcio e basket: potrebbe essere utile per prevedere lo sviluppo di lesioni muscolari e tendinee? 81
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 81
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 80
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 79
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 77
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 77
Valutazione dei fattori predittivi per il raggiungimento della remissione parziale (RP) secondo i criteri ASAS nei pazienti con Spondilite Anchilosante (SA) trattati con farmaci antagonisti del TNF 75
Psychological Health in the Management of Patients with Psoriatic Arthritis: An Intricate Relationship 73
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease 71
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 70
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review 69
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 68
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 68
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 64
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 64
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 63
Two sides of management recommendations for psoriatic arthritis 61
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 61
Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study 60
Sex-related differences in psoriatic arthritis 59
Livelli aumentati di IL19 nel liquido sinoviale di pazienti con artrite psoriasica 59
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 58
Elevated levels of IL-19 in the joints of patients with psoriatic arthritis 57
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 56
VALUTAZIONE DELLA REMISSIONE CLINICA SECONDO I CRITERI ASAS NEI PAZIENTI CON SPONDILOARTRITE ASSIALE TRATTATI CON FARMACI BIOLOGICI ANTAGONISTI DEL TNF ALPHA: STUDIO RETROSPETTIVO MULTICENTRICO 50
Totale 12.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022359 15 76 16 17 17 7 10 38 49 71 14 29
2022/20231.805 218 74 34 151 68 126 15 86 895 67 39 32
2023/2024473 132 68 34 19 23 51 2 33 17 23 19 52
2024/20251.668 319 69 193 21 285 36 21 96 163 55 174 236
2025/20266.178 205 482 705 377 1.418 1.207 619 243 253 535 101 33
Totale 12.195